CANNABIS PRODUCTS

$2M in repeat purchase orders display Creso Pharma’s growth potential

Finfeed Archived Oct 13, 2020

Creso Pharma Limited (ASX: CPH, FRA: 1X8) has once again strengthened its revenue profile with another repeat purchase order from South African-based Pharma Dynamics.

Canopy Growth Founder Joins a Refreshed, Re-Set and Re-Funded CPH

Next Investors Archived Oct 13, 2020

While Creso Pharma (ASX: CPH) continues to sign purchase orders and has appointed Bruce Linton as an advisor, it is a highly speculative investment, and our intent is to hold for the coming months through to Christmas to see how the company’s strategy plays out.

Creso Pharma to receive $8.92M funding: attracts Canopy Growth cannabis pioneer

Finfeed Archived Oct 07, 2020

World leading cannabis executive Bruce Linton has joined Creso Pharma (ASX: CPH) as a strategic advisor with a mandate to use his industry experience to progress the company’s global expansion.

Creso Pharma’s Mernova receives initial purchase order

Finfeed Archived Sep 21, 2020

Creso Pharma’s (ASX:CPH) Mernova Medicinal Inc based in Nova Scotia has received an initial purchase order for its cannabis products

Creso Pharma Secures New US$625,000 Purchase Order for Medicinal Cannabis

Finfeed Archived Jul 10, 2020

Creso Pharma's wholly-owned subsidiary Mernova Medicinal has received a purchase order for cannabis flower from Univo

Podcast: The future of the cannabis industry and what investors should expect

Finfeed Archived May 27, 2020

Here to speak with Finfeed today about the ups and downs of the cannabis industry, cannabis in Canada and what he sees is the future of the cannabis industry is COO and director of Embark Health, Mike Curtis.

MMJ Group upbeat about Embark Health’s first B2B sale

Finfeed Archived May 11, 2020

MMJ investee Embark Health has signed the group’s first business to business (B2B) sale of Bulk Bubble Hash.

The world in medical cannabis and weed this week

Finfeed Archived May 01, 2020

The final week in April has proven to be a big week in the cannabis sector, with several global milestones expected in May.

MMJ increases stake in Sequoya

Finfeed Archived Apr 16, 2020

MMJ Group Holdings Limited (ASX: MMJ/OTC: MMJJF) has agreed to provide a C$2.5 million secured convertible note facility to Sequoya Cannabis Limited.

MMJ Emerging from the Storm as Cannabis 2.0 Gathers Momentum

Next Investors Archived Apr 09, 2020

MMJ Group (ASX: MMJ) scours the globe evaluating the best opportunities in cannabis and is quietly amassing positions at discounted prices right now, as the sector is considered out of favour.

COVID-19 boosts cannabis sales by 159%

Finfeed Archived Mar 27, 2020

Reports show that anxiety-driven consumers are now stockpiling cannabis in at least four US states thanks to COVID-19.

Creso to release immunity boosting CBD hemp teas in Q3

Finfeed Archived Mar 24, 2020

The $9.9 million capped Australian-listed Creso Pharma Limited (ASX: CPH) is set to release CBD hemp teas in Q3 2020

Creso’s New Immunity Boosting CBD Hemp Teas Set for Release

Next Investors Archived Mar 24, 2020

Creso Pharma Limited (ASX: CPH) is expanding its available product line with the release of a hemp tea in Q3 2020.

Can cannabis companies rebound after COVID-19?

Finfeed Archived Mar 17, 2020

Will cannabis stocks survive the Coronavirus? The strong will survive and there could be bargains to be had.

CPH Secures Two Execs from the World’s Largest Cannabis Company

Next Investors Archived Mar 11, 2020

ASX Junior Creso Pharma (ASX: CPH) has appointed two former Canopy executives to the senior management team of its wholly-owned Mernova Medical Inc. in Nova Scotia, Canada.

MMJ’s Canadian cannabis investment Weed Me attracts new capital

Finfeed Archived Mar 10, 2020

Weed Me, one of the largest investments within MMJ Group’s cannabis and hemp portfolio, has completed a C$2.5 million capital raising.

Scandinavian Sales Agreement Expands Creso Pharma’s European Footprint

Next Investors Archived Mar 04, 2020

Creso Pharma Limited (ASX:CPH, FRA:1X8) has signed a commercial term sheet agreement with Farmagon, Oslo, Norway to enter the Scandinavia market with Creso products.

Creso Pharma agreement signals entry into Scandinavia

Finfeed Archived Mar 03, 2020

Creso Pharma Limited (ASX:CPH) has signed a commercial term sheet agreement with Farmagon, Oslo, Norway to enter the Scandinavia market with Creso products.

Cannabis Products